Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 608 (LINC00608) is a human long non-coding RNA gene located at chromosome 2q35 (base pairs 218,974,299 to 218,989,940)[3][1]. It belongs to the class of *long non-coding RNAs* (lncRNAs), which are transcribed RNA molecules longer than 200 nucleotides that do not encode proteins but may regulate gene expression at various levels, including chromatin modification, transcription, and post-transcriptional processing[7]. There is no evidence in current databases or literature that LINC00608 functions as a therapeutic target, drug target, enzyme, transporter, or receptor. It has been included in some genome-wide association and gene expression studies, often as part of panels for transcriptomic profiling or as a neighboring gene at loci associated with disease risk, but without direct implication as a functional driver or therapeutic target[1][7]. No drugs are currently known to target LINC00608, and it is not used as a clinical biomarker.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 608 (LINC00608).